Dyno Nobel (DNL) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
3 Feb, 2026Executive summary
Delivered strong FY2025 results, progressing transformation to a pure-play explosives business and achieving financial closure on fertilizer asset sales, with upfront cash proceeds of AUD 579 million.
Transformation program delivered AUD 134 million in cumulative EBIT benefits over two years, with a 23% EBIT increase year-over-year, and underlying explosives EBIT up 16%.
Safety performance improved, with a 19% reduction in TRIFR and no serious harm incidents.
Strategic focus on technology, capital discipline, and growth in EMEA and LATAM regions, with new leadership appointments and new growth vectors including the Nitradyn JV and expansion into defence energetics markets.
Financial highlights
Group statutory revenue was AUD 5,345 million (flat year-over-year), with EBITDA up 10% to AUD 1,012 million and EBIT up 23% to AUD 714 million.
Explosives underlying revenue grew 2% to AUD 2,970 million, with underlying EBIT up 16% to AUD 434 million.
Statutory after-tax loss of AUD 53 million, including AUD 477 million in IMIs related to asset sales and impairments.
Group ROIC increased to 8.2% (from 6.3%); excluding goodwill, ROIC at 11.5%.
Net debt to EBITDA at 1.4x, with AUD 930 million returned to shareholders under the AUD 1.4 billion capital return program.
Outlook and guidance
FY2026 explosives EBIT forecasted at AUD 460–500 million, with transformation benefits exit run rate targeted at 65–75% of the AUD 300 million ambition.
Earnings expected to be second-half weighted; debottlenecking at Moranbah to offset lost capacity from Gibson Island.
Capex for FY2026 forecast at AUD 280–330 million, with continued investment in customer growth and digital initiatives.
Phosphate Hill sale or closure targeted by March 2026, with capex of approximately AUD 35 million for safe operations.
Effective tax rate (excluding IMIs) expected at 20–25%.
Latest events from Dyno Nobel
- Strong financial results, strategic transformation, and robust shareholder support defined the AGM.DNL
AGM 20253 Feb 2026 - Doubling EBIT in 3–4 years, tech-driven growth, and strong capital returns targeted.DNL
Investor Showcase 20243 Feb 2026 - Fertilizer sale talks end; AUD 900m buyback begins, with FY24 outlook steady.DNL
Investor Update3 Feb 2026 - Record explosives and fertilisers results drive growth amid transformation and impairments.DNL
H2 202415 Jan 2026 - Transformation and asset sales drive profit recovery; stronger 2H expected.DNL
H1 202519 Nov 2025